|
Session 154-Poster Abstracts
TB Outcomes: HIV, ART, and Immune Mechanisms
Friday, 2-4 pm; Poster Hall |
782
 |
Effect of HIV Infection on Outcomes of Therapy for Pulmonary TB in 2 Clinical Trials
Erin Bliven*1, W Burman2, S Goldberg1, M Villarino1, J Johnson3, C Palmer1, R Chaisson4, and TB Trials Consortium Studies 27 and 28 Teams
1CDC, Atlanta, GA, US; 2Denver Publ Hlth, CO, US; 3Case Western Reserve Univ, Cleveland, OH, US; and 4Johns Hopkins Univ, Baltimore, MD, US |
783
|
The Association of TB Treatment Duration and Intermittency with Death and TB Recurrence Risk in HIViInfected Persons
Claudia Cortes*1, C McGowan2, F Wehbe2, S Duda2, B Shepherd2, P Leger3, D Masys2, T Sterling2, and CCASA-net of the IeDEA
1Univ of Chile, Santiago; 2Vanderbilt Univ, Nashville, TN, US; and 3GHESKIO, Port-au-Prince, Haiti |
784
|
Immunologic Benefits Associated with Suppression of HIV Replication during Treatment for HIV/TB Co-infection
Christina Lancioni*1, S Mahan1,2, D Johnson1, M Walusimbi3, E Charlebois4, R Mugerwa3, D Havlir4, H Boom1, and C Whalen5
1Case Western Reserve Univ, Cleveland, OH, US; 2MetroHlth Med Ctr, Cleveland, OH, US; 3Makerere Univ Sch of Med, Kampala, Uganda; 4Univ of California, San Francisco, US; and 5Univ of Georgia, Athens, US |
785
|
Functional Responses of Mycobacterial-specific CD4+ T Cells Are Maintained in Individuals Co-infected with HIV and TB
Hama Abdoulaye Diallo*1, A Tounkara1, Y Sarro1, O Guindo1, M Tall1, A Hammond1, M Polis2, M Catalfamo2, S Siddiqui2, and SEREFO Group
1Faculty of Med, Pharmacy and Dentistry, Univ of Bamako, Mali and 2NIAID, NIH, Bethesda, MD, US |
786
|
Multiple Cytokines Induced by a New Effective Booster Vaccine against HIV-associated TB
Timothy Lahey*1, S Sheth1, M Matee2, M Bakari2, R Arbeit3, R Horsburgh4, F von Reyn1, and the DarDar Study
1Dartmouth Med Sch, NH, US; 2Muhimbili Univ of Hlth and Allied Sci, Dar es Salaam, Tanzania; 3Tufts Univ Sch of Med, Boston, MA, US; and 4Boston Univ Sch of Publ Hlth, MA, US |
|
